Latest filings (excl ownership)
DEFR14A
Revised proxy
3 May 24
DEF 14A
Definitive proxy
29 Apr 24
10-K
2023 FY
Annual report
9 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
8-K
Results of Operations and Financial Condition
1 Apr 24
424B5
Prospectus supplement for primary offering
21 Feb 24
8-K
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders
21 Feb 24
8-K
Regulation FD Disclosure
31 Jan 24
8-K
Departure of Directors or Certain Officers
16 Jan 24
8-K
Entry into a Material Definitive Agreement
29 Dec 23
8-K
Departure of Directors or Certain Officers
12 Dec 23
8-K
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
11 Dec 23
8-K
NEXGEL Acquires Kenkoderm Psoriasis Skincare Line
5 Dec 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
13 Nov 23
8-K
NEXGEL Secures Supply Agreement with AbbVie
30 Oct 23
8-K
NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-Year
14 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
9 Jun 23
EFFECT
Notice of effectiveness
8 Jun 23
CORRESP
Correspondence with SEC
7 Jun 23
CORRESP
Correspondence with SEC
7 Jun 23
8-K
Regulation FD Disclosure
6 Jun 23
S-3/A
Shelf registration (amended)
26 May 23
8-K
NEXGEL Reports First Quarter 2023 Financial Results
15 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
DEF 14A
Definitive proxy
27 Apr 23
10-K
2022 FY
Annual report
27 Mar 23
8-K
NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results
27 Mar 23
8-K
Other Events
23 Mar 23
8-K
NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business
2 Mar 23
8-K
NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee
17 Jan 23
8-K
Entry into a Material Definitive Agreement
6 Jan 23
8-K
NEXGEL Announces Share Repurchase Program
7 Dec 22
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
NEXGEL Reports Third Quarter 2022 Financial Results
8 Nov 22
8-K
Termination of a Material Definitive Agreement
9 Sep 22
8-K
Submission of Matters to a Vote of Security Holders
6 Sep 22
8-K
NEXGEL Reports Second Quarter 2022 Financial Results
10 Aug 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
Latest ownership filings
4
Scott Robert Henry
5 Mar 24
4
steven mark glassman
5 Mar 24
4
Adam E Drapczuk III
5 Mar 24
4
steven mark glassman
26 Dec 23
4
John Nachum Stein
28 Sep 23
4
Scott Robert Henry
14 Sep 23
4
Scott Robert Henry
23 Aug 23
4
Miranda Jayne Toledano
21 Aug 23
4
JEROME B ZELDIS
21 Aug 23
4
John Nachum Stein
21 Aug 23
4
DAVID STEFANSKY
21 Aug 23
4
steven mark glassman
21 Aug 23
4
Scott Robert Henry
21 Aug 23
4
Scott Robert Henry
12 Jun 23
4
John Nachum Stein
9 Jun 23
4
DAVID STEFANSKY
9 Jun 23
4
Scott Robert Henry
2 Jun 23
4
DAVID STEFANSKY
1 Jun 23
4
steven mark glassman
1 Jun 23
4
JEROME B ZELDIS
30 May 23
4
Scott Robert Henry
24 May 23
3
Scott Robert Henry
17 Jan 23
4
DAVID STEFANSKY
19 Dec 22
4
DAVID STEFANSKY
13 Dec 22
4/A
NACHUM STEIN
2 Dec 22
4
NACHUM STEIN
1 Dec 22
4
DAVID STEFANSKY
31 Aug 22
4
Yaakov Spinrad
31 Aug 22
4
DAVID STEFANSKY
26 Aug 22
4
DAVID STEFANSKY
17 Aug 22
4
DAVID STEFANSKY
27 Jun 22
4
Adam E Drapczuk III
31 May 22
4
NACHUM STEIN
28 Mar 22
4
Adam R. Levy
28 Mar 22
4
JEROME B ZELDIS
28 Mar 22
4
steven mark glassman
28 Mar 22
4
JEROME B ZELDIS
3 Jan 22
4
Miranda Jayne Toledano
3 Jan 22
4
NACHUM STEIN
3 Jan 22
4
DAVID STEFANSKY
3 Jan 22